Stock Information
Evommune Inc (EVMN)
Ticker Symbol: EVMN
Exchange: NYSE
Sector: Biotechnology
Market Cap: $441.95 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.83
Revenue (TTM): $0.36 M
Dividend Yield: N/A
ROE: -46.76%
Latest News
-
Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 Congress
Wed, Sep 23, 2026 8:05 PM
-
Evommune To Present Results From Phase 2a Study Of EVO301 In Moderate-To-Severe Atopic Dermatitis At European Academy Of Dermatology & Venereology Congress
Wed, Sep 23, 2026 4:06 PM
-
Evommune: Pipeline Reset After EVO756 Failure, All Eyes On EVO301
Tue, Sep 22, 2026 6:05 AM
Key Financials
Financial data not available
